-
1
-
-
84911474269
-
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014; 25: iii1-9
-
(2014)
Ann Oncol
, vol.25
-
-
Van Cutsem, E.1
Cervantes, A.2
Nordlinger, B.3
Arnold, D.4
-
2
-
-
77449130761
-
Microsatellite instability in colorectal cancer
-
Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010; 138: 2073-2087 e3
-
(2010)
Gastroenterology
, vol.138
, pp. 2073-2087
-
-
Boland, C.R.1
Goel, A.2
-
3
-
-
0038002279
-
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
-
Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003; 349: 247-257
-
(2003)
N Engl J Med
, vol.349
, pp. 247-257
-
-
Ribic, C.M.1
Sargent, D.J.2
Moore, M.J.3
Thibodeau, S.N.4
French, A.J.5
Goldberg, R.M.6
Hamilton, S.R.7
Laurent-Puig, P.8
Gryfe, R.9
Shepherd, L.E.10
Tu, D.11
Redston, M.12
Gallinger, S.13
-
4
-
-
10744228074
-
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
-
Carethers JM, Smith EJ, Behling CA, Nguyen L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K, Boland CR. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology. 2004; 126: 394-401
-
(2004)
Gastroenterology
, vol.126
, pp. 394-401
-
-
Carethers, J.M.1
Smith, E.J.2
Behling, C.A.3
Nguyen, L.4
Tajima, A.5
Doctolero, R.T.6
Cabrera, B.L.7
Goel, A.8
Arnold, C.A.9
Miyai, K.10
Boland, C.R.11
-
5
-
-
59249097606
-
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
-
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Rene JM, Clofent J, Bessa X, et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. European Journal of Cancer. 2009; 45: 365-373
-
(2009)
European Journal of Cancer
, vol.45
, pp. 365-373
-
-
Jover, R.1
Zapater, P.2
Castells, A.3
Llor, X.4
Andreu, M.5
Cubiella, J.6
Balaguer, F.7
Sempere, L.8
Xicola, R.M.9
Bujanda, L.10
Rene, J.M.11
Clofent, J.12
Bessa, X.13
-
6
-
-
33646798052
-
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
-
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Pinol V, Xicola RM, Bujanda L, Rene JM, Clofent J, Bessa X, Morillas JD, et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut. 2006; 55: 848-855
-
(2006)
Gut
, vol.55
, pp. 848-855
-
-
Jover, R.1
Zapater, P.2
Castells, A.3
Llor, X.4
Andreu, M.5
Cubiella, J.6
Pinol, V.7
Xicola, R.M.8
Bujanda, L.9
Rene, J.M.10
Clofent, J.11
Bessa, X.12
Morillas, J.D.13
-
7
-
-
77954748953
-
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
-
Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010; 28: 3219-3226
-
(2010)
J Clin Oncol
, vol.28
, pp. 3219-3226
-
-
Sargent, D.J.1
Marsoni, S.2
Monges, G.3
Thibodeau, S.N.4
Labianca, R.5
Hamilton, S.R.6
French, A.J.7
Kabat, B.8
Foster, N.R.9
Torri, V.10
Ribic, C.11
Grothey, A.12
Moore, M.13
-
8
-
-
0032146118
-
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability
-
Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998; 58: 3455-3460
-
(1998)
Cancer Res
, vol.58
, pp. 3455-3460
-
-
Cunningham, J.M.1
Christensen, E.R.2
Tester, D.J.3
Kim, C.Y.4
Roche, P.C.5
Burgart, L.J.6
Thibodeau, S.N.7
-
9
-
-
17144441735
-
Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening
-
Potocnik U, Glavac D, Golouh R, Ravnik-Glavac M. Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet. 2001; 126: 85-96
-
(2001)
Cancer Genet Cytogenet
, vol.126
, pp. 85-96
-
-
Potocnik, U.1
Glavac, D.2
Golouh, R.3
Ravnik-Glavac, M.4
-
10
-
-
9644270289
-
The mismatch repair complex hMutSa recognizes 5-fluorouracil-modified DNA: Implications for chemosensitivity and resistance
-
Tajima A, Hess MT, Cabrera BL, Kolodner RD, Carethers JM. The mismatch repair complex hMutSa recognizes 5-fluorouracil-modified DNA: Implications for chemosensitivity and resistance. Gastroenterology. 2004; 127: 1678-1684
-
(2004)
Gastroenterology
, vol.127
, pp. 1678-1684
-
-
Tajima, A.1
Hess, M.T.2
Cabrera, B.L.3
Kolodner, R.D.4
Carethers, J.M.5
-
11
-
-
82555187429
-
Both hMutSalpha and hMutSss DNA Mismatch Repair Complexes Participate in 5-Fluorouracil Cytotoxicity
-
Tajima A, Iwaizumi M, Tseng-Rogenski S, Cabrera BL, Carethers JM. Both hMutSalpha and hMutSss DNA Mismatch Repair Complexes Participate in 5-Fluorouracil Cytotoxicity. PLoS One. 2011; 6: e28117
-
(2011)
PLoS One
, vol.6
-
-
Tajima, A.1
Iwaizumi, M.2
Tseng-Rogenski, S.3
Cabrera, B.L.4
Carethers, J.M.5
-
12
-
-
14044264185
-
DNA mismatch repair-dependent response to fluoropyrimidine-generated damage
-
Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, Boothman DA. DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem. 2005; 280: 5516-5526
-
(2005)
J Biol Chem
, vol.280
, pp. 5516-5526
-
-
Meyers, M.1
Wagner, M.W.2
Mazurek, A.3
Schmutte, C.4
Fishel, R.5
Boothman, D.A.6
-
13
-
-
80054110823
-
DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells
-
Iwaizumi M, Tseng-Rogenski S, Carethers JM. DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells. Cancer Biol Ther. 2011; 12: 756-764
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 756-764
-
-
Iwaizumi, M.1
Tseng-Rogenski, S.2
Carethers, J.M.3
-
14
-
-
84864350983
-
Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours
-
Doi T, Ohtsu A, Yoshino T, Boku N, Onozawa Y, Fukutomi A, Hironaka S, Koizumi W, Sasaki T. Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours. Br J Cancer. 2012; 107: 429-434
-
(2012)
Br J Cancer
, vol.107
, pp. 429-434
-
-
Doi, T.1
Ohtsu, A.2
Yoshino, T.3
Boku, N.4
Onozawa, Y.5
Fukutomi, A.6
Hironaka, S.7
Koizumi, W.8
Sasaki, T.9
-
15
-
-
84866925889
-
TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial
-
Yoshino T, Mizunuma N, Yamazaki K, Nishina T, Komatsu Y, Baba H, Tsuji A, Yamaguchi K, Muro K, Sugimoto N, Tsuji Y, Moriwaki T, Esaki T, et al. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol. 2012; 13: 993-1001
-
(2012)
Lancet Oncol
, vol.13
, pp. 993-1001
-
-
Yoshino, T.1
Mizunuma, N.2
Yamazaki, K.3
Nishina, T.4
Komatsu, Y.5
Baba, H.6
Tsuji, A.7
Yamaguchi, K.8
Muro, K.9
Sugimoto, N.10
Tsuji, Y.11
Moriwaki, T.12
Esaki, T.13
-
16
-
-
84929310633
-
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
-
Mayer RJ, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med. 2015; 372: 1909-1919
-
(2015)
N Engl J Med
, vol.372
, pp. 1909-1919
-
-
Mayer, R.J.1
Van Cutsem, E.2
Falcone, A.3
Yoshino, T.4
Garcia-Carbonero, R.5
Mizunuma, N.6
Yamazaki, K.7
Shimada, Y.8
Tabernero, J.9
Komatsu, Y.10
Sobrero, A.11
Boucher, E.12
Peeters, M.13
-
17
-
-
84928530913
-
Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA
-
Sakamoto K, Yokogawa T, Ueno H, Oguchi K, Kazuno H, Ishida K, Tanaka N, Osada A, Yamada Y, Okabe H, Matsuo K. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA. Int J Oncol. 2015; 46: 2327-2334
-
(2015)
Int J Oncol
, vol.46
, pp. 2327-2334
-
-
Sakamoto, K.1
Yokogawa, T.2
Ueno, H.3
Oguchi, K.4
Kazuno, H.5
Ishida, K.6
Tanaka, N.7
Osada, A.8
Yamada, Y.9
Okabe, H.10
Matsuo, K.11
-
18
-
-
79955981402
-
Mode of action of trifluorothymidine (TFT) against DNA replication and repair enzymes
-
Suzuki N, Emura T, Fukushima M. Mode of action of trifluorothymidine (TFT) against DNA replication and repair enzymes. Int J Oncol. 2011; 39: 263-270
-
(2011)
Int J Oncol
, vol.39
, pp. 263-270
-
-
Suzuki, N.1
Emura, T.2
Fukushima, M.3
-
19
-
-
37549061057
-
Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells
-
Abdel-Rahman WM, Knuutila S, Peltomaki P, Harrison DJ, Bader SA. Truncation of MBD4 predisposes to reciprocal chromosomal translocations and alters the response to therapeutic agents in colon cancer cells. DNA Repair (Amst). 2008; 7: 321-328
-
(2008)
DNA Repair (Amst)
, vol.7
, pp. 321-328
-
-
Abdel-Rahman, W.M.1
Knuutila, S.2
Peltomaki, P.3
Harrison, D.J.4
Bader, S.A.5
-
20
-
-
84877927182
-
MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles
-
Sjolund AB, Senejani AG, Sweasy JB. MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles. Mutat Res. 2013; 743-744: 12-25
-
(2013)
Mutat Res
, vol.743-744
, pp. 12-25
-
-
Sjolund, A.B.1
Senejani, A.G.2
Sweasy, J.B.3
-
21
-
-
0037965916
-
Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis
-
Screaton RA, Kiessling S, Sansom OJ, Millar CB, Maddison K, Bird A, Clarke AR, Frisch SM. Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: a potential link between genome surveillance and apoptosis. Proc Natl Acad Sci U S A. 2003; 100: 5211-5216
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 5211-5216
-
-
Screaton, R.A.1
Kiessling, S.2
Sansom, O.J.3
Millar, C.B.4
Maddison, K.5
Bird, A.6
Clarke, A.R.7
Frisch, S.M.8
-
22
-
-
0033599013
-
Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency
-
Bader S, Walker M, Hendrich B, Bird A, Bird C, Hooper M, Wyllie A. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene. 1999; 18: 8044-8047
-
(1999)
Oncogene
, vol.18
, pp. 8044-8047
-
-
Bader, S.1
Walker, M.2
Hendrich, B.3
Bird, A.4
Bird, C.5
Hooper, M.6
Wyllie, A.7
-
23
-
-
0032743063
-
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
-
Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE, Ruggeri BA, Klein-Szanto AJ, Testa JR, et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet. 1999; 23: 266-268
-
(1999)
Nat Genet
, vol.23
, pp. 266-268
-
-
Riccio, A.1
Aaltonen, L.A.2
Godwin, A.K.3
Loukola, A.4
Percesepe, A.5
Salovaara, R.6
Masciullo, V.7
Genuardi, M.8
Paravatou-Petsotas, M.9
Bassi, D.E.10
Ruggeri, B.A.11
Klein-Szanto, A.J.12
Testa, J.R.13
-
24
-
-
0034543135
-
Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations
-
Bader S, Walker M, Harrison D. Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations. Br J Cancer. 2000; 83: 1646-1649
-
(2000)
Br J Cancer
, vol.83
, pp. 1646-1649
-
-
Bader, S.1
Walker, M.2
Harrison, D.3
-
25
-
-
84969753170
-
Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status
-
Suzuki S, Iwaizumi M, Tseng-Rogenski S, Hamaya Y, Miyajima H, Kanaoka S, Sugimoto K, Carethers JM. Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status. Cancer Biol Ther. 2016; 17: 760-768
-
(2016)
Cancer Biol Ther
, vol.17
, pp. 760-768
-
-
Suzuki, S.1
Iwaizumi, M.2
Tseng-Rogenski, S.3
Hamaya, Y.4
Miyajima, H.5
Kanaoka, S.6
Sugimoto, K.7
Carethers, J.M.8
-
26
-
-
0034693039
-
Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase
-
Petronzelli F, Riccio A, Markham GD, Seeholzer SH, Stoerker J, Genuardi M, Yeung AT, Matsumoto Y, Bellacosa A. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem. 2000; 275: 32422-32429
-
(2000)
J Biol Chem
, vol.275
, pp. 32422-32429
-
-
Petronzelli, F.1
Riccio, A.2
Markham, G.D.3
Seeholzer, S.H.4
Stoerker, J.5
Genuardi, M.6
Yeung, A.T.7
Matsumoto, Y.8
Bellacosa, A.9
-
27
-
-
65949089155
-
Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil
-
Kunz C, Focke F, Saito Y, Schuermann D, Lettieri T, Selfridge J, Schar P. Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil. PLoS Biol. 2009; 7: e91
-
(2009)
PLoS Biol
, vol.7
-
-
Kunz, C.1
Focke, F.2
Saito, Y.3
Schuermann, D.4
Lettieri, T.5
Selfridge, J.6
Schar, P.7
-
28
-
-
33847057392
-
5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity
-
An Q, Robins P, Lindahl T, Barnes DE. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity. Cancer Res. 2007; 67: 940-945
-
(2007)
Cancer Res
, vol.67
, pp. 940-945
-
-
An, Q.1
Robins, P.2
Lindahl, T.3
Barnes, D.E.4
-
29
-
-
16244423009
-
Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts
-
Andersen S, Heine T, Sneve R, Konig I, Krokan HE, Epe B, Nilsen H. Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. Carcinogenesis. 2005; 26: 547-555
-
(2005)
Carcinogenesis
, vol.26
, pp. 547-555
-
-
Andersen, S.1
Heine, T.2
Sneve, R.3
Konig, I.4
Krokan, H.E.5
Epe, B.6
Nilsen, H.7
-
30
-
-
0012395179
-
Fluorinated Pyrimidines XXVI. Mammalian Thymidylate Synthetase: Its Mechanism of Action and Inhibition by Fluorinated Nucleotides
-
Reyes P, Heidelberger C. Fluorinated Pyrimidines XXVI. Mammalian Thymidylate Synthetase: Its Mechanism of Action and Inhibition by Fluorinated Nucleotides. Molecular Pharmacology. 1965; 1: 14-30
-
(1965)
Molecular Pharmacology
, vol.1
, pp. 14-30
-
-
Reyes, P.1
Heidelberger, C.2
-
31
-
-
84891628249
-
Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase
-
Nakamura A, Nakajima G, Okuyama R, Kuramochi H, Kondoh Y, Kanemura T, Takechi T, Yamamoto M, Hayashi K. Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. Gastric Cancer. 2014; 17: 188-195
-
(2014)
Gastric Cancer
, vol.17
, pp. 188-195
-
-
Nakamura, A.1
Nakajima, G.2
Okuyama, R.3
Kuramochi, H.4
Kondoh, Y.5
Kanemura, T.6
Takechi, T.7
Yamamoto, M.8
Hayashi, K.9
-
32
-
-
85011333645
-
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
-
Niedzwiecki D, Hasson RM, Lenz HJ, Ye C, Redston M, Ogino S, Fuchs CS, Compton CC, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS, et al. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803. Oncologist. 2017; 22: 107-114
-
(2017)
Oncologist
, vol.22
, pp. 107-114
-
-
Niedzwiecki, D.1
Hasson, R.M.2
Lenz, H.J.3
Ye, C.4
Redston, M.5
Ogino, S.6
Fuchs, C.S.7
Compton, C.C.8
Mayer, R.J.9
Goldberg, R.M.10
Colacchio, T.A.11
Saltz, L.B.12
Warren, R.S.13
-
33
-
-
33847233256
-
A human cancerassociated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells
-
Bader SA, Walker M, Harrison DJ. A human cancerassociated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells. Br J Cancer. 2007; 96: 660-666
-
(2007)
Br J Cancer
, vol.96
, pp. 660-666
-
-
Bader, S.A.1
Walker, M.2
Harrison, D.J.3
-
34
-
-
0033616583
-
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1
-
Bellacosa A, Cicchillitti L, Schepis F, Riccio A, Yeung AT, Matsumoto Y, Golemis EA, Genuardi M, Neri G. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A. 1999; 96: 3969-3974
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 3969-3974
-
-
Bellacosa, A.1
Cicchillitti, L.2
Schepis, F.3
Riccio, A.4
Yeung, A.T.5
Matsumoto, Y.6
Golemis, E.A.7
Genuardi, M.8
Neri, G.9
-
35
-
-
0027936057
-
Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation
-
Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 1994; 54: 4308-4312
-
(1994)
Cancer Res
, vol.54
, pp. 4308-4312
-
-
Koi, M.1
Umar, A.2
Chauhan, D.P.3
Cherian, S.P.4
Carethers, J.M.5
Kunkel, T.A.6
Boland, C.R.7
-
36
-
-
84891938948
-
Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line
-
Takahashi K, Tanaka M, Inagaki A, Wanibuchi H, Izumi Y, Miura K, Nagayama K, Shiota M, Iwao H. Establishment of a 5-fluorouracil-resistant triple-negative breast cancer cell line. Int J Oncol. 2013; 43: 1985-1991
-
(2013)
Int J Oncol
, vol.43
, pp. 1985-1991
-
-
Takahashi, K.1
Tanaka, M.2
Inagaki, A.3
Wanibuchi, H.4
Izumi, Y.5
Miura, K.6
Nagayama, K.7
Shiota, M.8
Iwao, H.9
-
37
-
-
84898621979
-
ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays
-
Guzman C, Bagga M, Kaur A, Westermarck J, Abankwa D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS One. 2014; 9: e92444
-
(2014)
PLoS One
, vol.9
-
-
Guzman, C.1
Bagga, M.2
Kaur, A.3
Westermarck, J.4
Abankwa, D.5
|